Sponsor:
Endo USA Inc., a Keenova Therapeutics Company
Code:
NCT07846280
Conditions
Flexible Hammertoe
Semi-flexible Hammertoe
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
KN3835
Brief summary:
Conditions
Flexible Hammertoe
Semi-flexible Hammertoe
Study ID
NCT07846280
Start date
Oct 15, 2026
Status verified date
Nov, 2026
Completion date
Dec, 2028
Anticipated
Primary completion date
Dec, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
470 participants
Anticipated
Allocation
Non randomized
Intervention Model
Sequential
Primary purpose
Treatment
Arms
experimental: Observation then KN3835
no intervention: Observation Only
Interventions
KN3835
Primary outcome measure
Central contacts
Locations
Keenova Site-008
Recruiting
Tarzana, California, United States, 91356
Principal Investigator:
Fardin Hakakian
Keenova Site-004
Recruiting
Pinellas Park, Florida, United States, 33782
Principal Investigator:
Jason Levy
Keenova Site-007
Recruiting
Sweetwater, Florida, United States, 33172
Principal Investigator:
Edward Gonzalez
Keenova Site-006
Recruiting
Salt Lake City, Utah, United States, 84107
Principal Investigator:
Clark Larsen
Sponsor
Endo USA Inc., a Keenova Therapeutics Company
Last update posted
Nov 16, 2026
Last verified
Nov, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-17. This information was provided to ClinicalTrials.gov by Endo USA Inc., a Keenova Therapeutics Company on 2026-11-16. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.